Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Preliminary Phase II Data of Setmelanotide in Prader-Willi Syndrome and Next Steps - Slideshow

SA Transcripts157.4K FollowersFollow5ShareSaveCommentsThe following slide deck was published by Rhythm Pharmaceuticals, Inc. in conjunction with this event. This article was written bySA Transcripts157.4K FollowersFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team